Article
Michael Z. Liao, Dan Lu, Matts Kågedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li
My Company has been sold, now what?!?”
Summary
In this episode, Tom Caravela welcomes Steve St. Onge to discuss the intricacies of corporate acquisitions within the pharmaceutical industry. Steve shares his journey through corporate development and provides insight into the transition and management of acquisitions, both before and after announcements. The conversation delves into the emotional and strategic aspects of navigating acquisitions, identifying warning signs, and the impact of market volatility. Steve offers practical advice for decision-making during economic downturns and strategies for embracing change and new opportunities in the pharma sector. The episode concludes with a discussion on future innovation and optimism in biotech, along with closing remarks and gratitude to listeners.
Steve St. Onge, Sr Director Business Development and Corporate Communications at Paratek discusses what to expect after your company has been acquired.
Steve shares….
👉 What to expect when acquisition news hits
👉 How to handle emotions and not panic
👉 What steps you should take after acquisition news
👉 What are the warning signs to be aware of
👉 Why is the pharma / biotech sector so volatile these days
pharmaceutical acquisitions, corporate development, biotech innovation, market volatility, economic downturn strategies
Related Topics
You May Also Like
Michael Z. Liao, Dan Lu, Matts Kågedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li
Podcast
MSL Talk: Tom Caravela, Josh Corriveau
MSL Career Options: The transition from Field Medical to Medical Director
Article
Shubham Sharma, J Connor Wells, Wilma M Hopman, Joseph C Del Paggio, Bishal Gyawali, Nazik Hammad, Annette E Hay, Christopher M Booth
Cancer, Clinical Trials, and Canada: Our Contribution to Worldwide Randomized Controlled Trials
Article
Sarah A. Weiss, MD, and Harriet Kluger, MD
CheckMate-067: Raising the Bar for the Next Decade in Oncology
Article
Sonoko Kawakatsu, René Bruno, Matts Kågedal, Chunze Li, Sandhya Girish, Amita Joshi, Benjamin Wu
Confounding factors in exposure–response analyses and mitigation strategies for monoclonal antibodies in oncology
Article
Barbara Kiesewetter , Nathan I Cherny, Nicolas Boissel, Francesco Cerisoli, Urania Dafni, Elisabeth G E de Vries, Paolo Ghia, Nicola Gökbuget, Verónica González-Calle, Brian Huntly, Ulrich Jäger, Nicola Jane Latino, Jean-Yves Douillard, Luca Malcovati, Ma